Littler Mendelson, P.C. (Littler), the nation’s largest employment and labor law firm representing management, has added Rebecca M. Aragon as a shareholder in its Los Angeles office. Ms. Aragon, formerly chair of the Labor and Employment Practice Group at Venable LLP in Los Angeles, brings more than 20 years of legal experience and will divide her time between the firm’s downtown and Century City offices (more…)
O’Melveny & Myers LLP represented Celsion Corporation, a leading oncology company dedicated to the development and commercialization of innovative cancer drugs, in the closing of a US$15 million private placement that includes commitments by leading life science institutional investors (more…)
Fenwick & West represented SuccessFactors, Inc. (NYSE: SFSF) in its acquisition by SAP America, Inc. (NYSE: SAP). The transaction is valued at approximately $3.4 billion (more…)
Shearman & Sterling represented BofA Merrill Lynch, Morgan Stanley, Barclays Capital and Deutsche Bank as joint book-running managers and representatives of the several managers in connection with Amgen’s offering of €550,000,000 4.375% Senior Notes due 2018 and £475,000,000 5.50% Senior Notes due 2026. The offering was conducted in accordance with Regulation S (more…)
Hughes Hubbard & Reed announced today that David Stern, a litigation partner with considerable first chair trial experience, has joined the firm in its Los Angeles office. He was previously a partner at Winston & Strawn in L.A. (more…)
Brown Eassa & McLeod is pleased to announce that Lisa Jones has joined the firm’s Los Angeles Office (more…)
A team of lawyers from Dewey & LeBoeuf’s Silicon Valley and New York offices represented Synopsys, Inc., a world leader in electronic design automation (EDA), on its definitive agreement to acquire Magma Design Automation Inc., a publicly traded provider of chip design software headquartered in San Jose, California, for more than $500 million (more…)
Davis Polk is advising Affymetrix, Inc. on its approximately $330 million acquisition of eBioscience Holding Company, Inc. The transaction, which is expected to close in the fourth quarter of 2011, is subject to customary regulatory approvals and closing conditions, including receipt by Affymetrix of the proceeds of the debt financing for the transaction (more…)
